
Drug that cuts risk of breast cancer returning is approved for use in England
Thousands of women with early breast cancer could be offered a drug to stop the cancer returning, after the medicines watchdog approved its use in England. Up to 4,000 patients a year could be given ribociclib alongside hormone therapy, for hormone …